Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE

OBJECTIVE: Our aim was to provide practical recommendations on the management of patients with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after docetaxel plus androgen-deprivation therapy (ADT) or abiraterone plus ADT. METHODS: Systematic literature review (SLR), nom...

Descripción completa

Detalles Bibliográficos
Autores principales: Puente, Javier, Anido, Urbano, Climent, Miguel Ángel, Gonzalez-Billalabeitia, Enrique, Lainez, Nuria, Lambea, Julio, Maroto, José Pablo, Mendez-Vidal, Maria Jose, Montesa, Álvaro, Rodriguez, Angel, Zambrana, Curro, González-del-Alba, Aránzazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517999/
https://www.ncbi.nlm.nih.gov/pubmed/33014145
http://dx.doi.org/10.1177/1758835920920067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7517999/
https://www.ncbi.nlm.nih.gov/pubmed/33014145
http://dx.doi.org/10.1177/1758835920920067

Ejemplares similares